Genetics of obesity

All unapproved Citizendium articles may contain errors of fact, bias, grammar etc. A version of an article is unapproved unless it is marked as citable with a dedicated green template at the top of the page, as in this version of the 'Biology' article. Citable articles are intended to be of reasonably high quality. The participants in the Citizendium project make no representations about the reliability of Citizendium articles or, generally, their suitability for any purpose. This article is currently being developed as part of an Eduzendium student project in the framework of a course entitled Appetite and Obesity at University of Edinburgh. The course homepage can be found at CZ:(U00984) Appetite and Obesity, University of Edinburgh 2010. For the course duration, the article is closed to outside editing. Of course you can always leave comments on the discussion page. The anticipated date of course completion is 01 February 2011. One month after that date at the latest, this notice shall be removed. Besides, many other Citizendium articles welcome your collaboration!

Obesity is the condition of excessive fat accummulation typically defined as a BMI of 30 or more. It presents as a major risk factor for premature mortality and is attributable to a number of chronic diseases: cardiovascular, metabolic and cancerous . With the onset of the obesity epidemic, an increasing number of institutions are researching into the causes of this current trend. While the environmental influences (including the ease of access to high energy palatable foods and sedentary lifestyle) cannot be neglected, there is much focus on genomics to explain inter-individual variation in susceptibility to adiposity.

Leptin pathway

Although several genes have been identified, they are limited to monogenic causes. Many of these are mutations of proteins in the “leptin pathway” which has an important role in energy balance. Each of those represented in the diagram has been shown to cause obesity, most often through twin studies.

In the case of all (except for MC4R) the quantity of mutations remains insignificant in the average population. However these findings do suggest there can be more common multifactorial influences on susceptibility to adiposity which are likely to be involved in similar pathways (7).

Population genetics

Pima Indians

The Pima Indian population represents a useful model for demonstrating the potential impact of genetic factors in influencing obesity. The Pima once resided in the deserts of Mexico where resources were scarce, however some migrated and communities now exist in Arizona, USA. Those who settled in the US were presented with a relative abundance of nourishment and exhibit extremely high levels of obesity and type 2 diabetes, whereas other communities of Pima do not. It has been proposed that genetic factors have protected this population in the past and allowed them to withstand conditions of deprivation, though if exposed to greater levels of food intake they are more susceptible to developing obesity as a result. This is known as the 'thrifty gene hypothesis'. [8]

Thrifty gene hypothesis

The thrifty gene hypothesis was first put forward by Neel in 1962 It states that, in history, a genotype that stores energy more efficiently in times of food abundance would have been advantageous to our ancestors to survive times of food shortage. It is widely accepted that this genotype has been naturally selected through years of food shortage but in modern day society has become a source health problems. These days food is almost always easily available so those showing the thrifty phenotype are in constant food storage mode preparing their bodies for a period of food shortage that never comes. This is suggested to be causing the widespread prevalence of obesity and type 2 diabetes in the developed world.

More recently this hypothesis has been challenged. Most noteably, JR Speakman highlighted some problems of the thrifty gene hypothesis in a review for the International Society of Diabetes Vascular Disease. He suggested that not enough significant famines have occurred in human populations and that mortality levels during these famines would not have been sufficient to lead to the levels of natural genotype selection that the thrifty gene hypothesis implies. Mortality patterns also do not fit with the hypothesis because deaths were often not due to starvation but due to disease, so the thrifty phenotype would not have been particularly advantageous and those age groups incurring the highest mortality rates would have been the very young and very old, and not those of reproductive age so gene selection for future generations would be unaffected. Whether the thrifty geneotype explains some of modern day obesity remains unclear as records of famine and mortality rates in history are not always well kept.

Polynesian Populations

Polynesia is a subregion of Oceania, encompassing more than 1000 islands over the central and southern Pacific Ocean. Polynesians share language, culture, beliefs and other features of society. The populations are interesting for study because of the relatively conserved gene pool, the concept of modernisation, and the migration of Polynesians to other countries. Polynesian populations exhibit high rates of type 2 diabetes and obesity, as shown in Samoans by McGarvey. However, increased rates of other obesity-associated problems such as metabolic syndrome and dyslipidaemia are not observed. Finally, a study in several Oceanic populations did not support Neel's thrifty gene hypothesis: population frequencies of common FTO polymorphisms displayed no significant association with BMI.

Monozygotic Twin Studies

Twin studies are useful for reliable investigation of the gene-environment interactions of obesity as they can yield more powerful data Using twins in a study by Bouchard et al shows whether the already known inter-individual effects of changes in energy balance or dietary interventions are due to genetic factors. For example, exposing monozygotic twins to positive energy balance/overfeeding lets us investigate whether differing sensitivities in individuals gaining fat when exposed to positive energy balance is dependent on genotype or not. Variables in phenotype measured in the study included; body weight, body composition, fat distribution, abdominal visceral fat and resting metabolic rate. The findings after overfeeding/exercise in the twins conveyed clear intrapair resemblance and variation between different twin pairs. This suggested the differences in susceptibility of overeating must be controlled mainly by genetic factors (which are thought to be inherited), though the exact genes involved in sensitivity of energy balance are currently not known.

Using monozygotic twin studies also allows measurement of the relationship between dietary factors and body fat independent of genetic factors. Both diet and genetic influences are thought to influence body fat. Using monozygotic twin studies it is possible to investigate the effect of diet on body fat independent of genotype. This therefore lets us analyse the extent genetics are involved in influencing body fat as no relationship between dietary fat and body fat was found in middle-aged women in a study conducted by Samaras et al , indicating that diet in determining total body fat may have been overestimated in the past and genetic factors are perhaps therefore more influential.

Monogenetic forms of Obesity

Mendelian Disorders

Obesity is a major clinical feature (but not the dominant feature) of some Mendelian disorders for which genetic mutations have been found. Prader-Willi syndrome is autosomal dominant and characterised by obesity, reduced foetal activity, mental retardation and hyperphagia which develops between the age of 1 and 2. Around three quarters of patients have a deletion on chromosome 15 (15q11-q13) and the remaining have maternal disomy. Albright hereditary osteodystrophy is a rare autosomal dominant disorder where patients are obese, short, mentally retarded and have subcutaneous calcifications. AHO is due to parental imprinting of mutations in the GNAS1 gene. The mutations for these have been established but, despite attempts, there has been no link between mutant genes and disrupted energy balance. It is likely that the underlying genetics that cause obesity in these Mendelian disorders are different to those in common forms of obesity, though further studies investigating genetic markers would need to be carried out.

Single-gene disorders

Leptin

Leptin is an endocrine hormone released from the adipocytes which allows information regarding energy stores to be transmitted to the brain, primarily the hypothalamus. It inhibits appetite by inhibiting orexigenic NYP/AgRP neurons in the arcuate nucleus and it stimulates metabolic rate. The levels circulating in the blood are proportional to amount of adipose tissue.

A very small number of patients worldwide have been found to have leptin mutations. Montague et al. investigated two morbidly obese hyperphagic children that were cousins with undetectable leptin. They were found to both be homozygous for deletion of a single guanine on codon 133, leading to a premature stop codon. The phenotype of these children is very like that of the ob/ob mice which are obese, hyperphagic, infertile and have hyperinsulinaemia. It was not possible to look into the reproductive effects of these children as they were pre-purbertal but it was speculated leptin is also required to intitate puberty.

Farooqi et al. treated these children with human recombinant leptin daily for a year, weighing them daily, carrying out DEXA scans, recorded food intake and measured other hormone levels such as insulin, thyrotrophin and gonadotrophins. They lost on average 1-2kg per month, their appetite decreased and all other hormones were normal. Their GnRH became pulsatile after 12 months indicating leptin may affect puberty onset.

Another mouse with a similar phenotype to ob/ob mouse is the db/db mouse. It has very high leptin and was found to have a leptin receptor mutation due to a premature stop codon which codes for a receptor without the intraceullar C terminal, which is necessary for tyrosine kinase activation. Only one family have been found to have a leptin receptor mutation which were homozygotes were hyperphagic, obese, growth retarded and had hypothalamic hypothyroidism. This indicates that the lack of receptors causes certain hypothalamic releasing factors to be impaired.

POMC

POMC (pre-pro-opiomelanocortin) is cleaved by prohormone convertases to form the melanocortin peptides adrenocorticotrophin (ACTH), melanocyte-stimulating hormones (MSH-alpha, beta and gamma) and beta-endorphin, an opiod receptor ligand. Discoveries about the link between alpha-MSH and regulation of food intake led to interest in the possible association of POMC with obesity. Scientists predicted, through knowledge of the normal physiology of POMC and melanocortin peptides, that the phenotype for POMC mutation would show obesity, pigmentation changes and ACTH deficiency. 2 patients showing this phenotype were initially found and sequencing of their POMC genes revealed mutations that abolished POMC function and therefore no melanocortin peptides could be detected in these patients.

Many single nucleotide polymorphisms have now been identified that cause POMC deficiency syndrome, characterised as early-onset obesity, hyperphagia, hypocortisolaemia due to ACTH deficiency and often red hair with pale skin due to lack of ligand for melanocortin-1 receptors. However, pigmentation changes may be obscured by differing genetic backgrounds. Patients homozygous for POMC-null mutations exclusively exhibit the obesity phenotype but this is extremely rare. Heterozygous patients have been shown by analysis of family pedigrees to be more prone to obesity.This has led to the suggestion that common obesity may be due to heterozygous genotypes for POMC mutations. In animal experiments, POMC-null heterozygous mice become obese on a high fat diet but remain slim on normal chow. This indicates that environmental influences could affect whether heterozygous obesity genes result in the obesity phenotype. Extensive screenings of obese cohorts which don’t display other POMC-deficiency syndromic effects have not been conclusive about whether POMC mutations cause common obesity. In one study, only 6 out of 601 obese patients showed mutations in the non-coding regions of the POMC gene which could be linked to their obesity. This suggests POMC mutations may not significantly contribute to common obesity.

MCR4

Melanocortins produced by POMC cleavage act on melanocortin receptors (e.g. MC-1R). The main subtype of Melanocortin recptor that is involed in feeding energy balance is MC-4. Mice homozygous for the MC-4R-null mutation show severe obesity and homozygotes show increased weight compared to wild type but less severe.Many human cases of heterozygous MC-4R mutations have now been identified and sequenced. In a large cohort of 2000 severly obese subjects 5-6% were found to have mutations of the MC-4R. More recent studies showed that 1-2.5% of subjects with a BMI over 30 had a MC-4R defect. These results suggest that MC-4R mutations are the most common genetic cause of obesity to date.

carboxypeptidase E

Genetic disruption to POMC and other prohormone post-translational processing has been linked to obesity due to lack of production of MC-4 ligands. Carboxypeptidase E (CPE) is an enzyme which processes prohormones. A naturally occurring mutation in the gene encoding CPE has been shown to cause obesity as in the fat/fat experimental mouse model. Being homozygous for the fat mutation results in obesity, exogenous insulin-sensitive hyperglycaemia, hyperproinsulinaemia and infertility. It has been shown that CPE is a receptor on the golgi membrane for prohormones like POMC to bind, which signals budding off of a prohormone-containing vesicle.Cleavage of prohormones in these vesicles is then mediated by prohormone convertases (Pc-1 and Pc-2) which are differentially regulated according to cells type to respond to nutritional and hormonal signals.Mice transgenically expressing an inactive form of PC-1 show an obese phenotype. This presents pharmacological potential to target specific steps in prohormone packaging and cleavage to aid weightloss.

FTO

Through modern genotyping technology, genome-wide association studies are now possible, allowing researchers to correlate genetic variants with particular traits on massive scales. It is through this method that polymorphisms in the FTO gene were identified as having significant influences on BMI in Caucasian individuals, in a study of a population of Sardinians by Scuteri et al (2007) [21]. The researchers examined genetic data from over 4,000 subjects and found strong associations between several Short-Nucleotide Repeats (SNPs) in the first intron of the FTO gene and BMI, hip circumference and total body weight. While shown to have only a modest influence of BMI; with each risk allele increasing body weight by around 1.3 to 2.1 kilograms, the frequency of risk allele expression is high in the European population at around 63% [22]. This is therefore a discovery with clinical relevance and represents a common genetic determinant of obesity. The normal biological purpose of the FTO gene is not well understood however, though it is believed to play a role in central appetite regulation. FTO mRNA has been found to be readily expressed in the feeding centres of the hypothalamus, including the supraoptic, ventromedial and arcuate nuclei. [23] It is apparent that individuals carrying the risk alleles for FTO will not inevitably suffer obesity. Nevertheless, the discovery of the FTO gene as a predisposition for increased body weight provoked excitement and speculation that further, commonly expressed polymorphisms may exist which account for differing susceptibilities to obesity amongst different individuals.

Polygenetic forms of Obesity

In contrast to the extremely rare cases of obesity caused by single-gene polymorphisms, subtle interactions between the polygenic variants in a range of genes are involved in a much larger proportion of cases. A polygene can only be identified and validated by statistically showing that such an allele occurs more frequently in obese patients than those that are not obese. Even once identified, each single polygene makes a tiny contribution to an obese phenotype. The nuances within obese phenotypes, with the additional effects of the environment, make determining the genetic basis of obesity extremely difficult. Candidate genes are selected on the basis of their involvement in pathways of energy balance or adipose tissue biology. Positive associations with an obese phenotype have been observed in >70 genes, but studies are not consistent and many associations have not been replicated in more than one study or population. Both knockout mice and human studies identified the genes for leptin and its receptor as candidate genes: polymorphisms in these coding regions showed positive associations with body weight, weight loss and BMI. Disappointingly, despite physiological data suggesting leptin’s important role in obesity, only a handful of mutations/single-nucleotide polymorphisms have been functionally associated. Association studies between obese phenotypes and other key proteins (POMC, AGRP, MC4R, NPY) are limited and require replication. A different approach is to us genome-wide scans to identify QTLs (quantitative trait loci), and eventually focus on specific genes within the chromosomal region. If strong evidence is found in an identified QTL, further more sensitive screening of that region is carried out with a denser map of markers. Strong evidence for a QTL influencing obesity was found on chromosome 2p22 and has been linked with leptin and adiponectin levels in further studies. Other QTLs with associations found include chromosomes 3q27, 5p-cen, 6p21-22, 7q, 10p, 11q23-24, 17p12, 20q11-13… New linkage methods have looked at pairwise correlation analyses and showed strong correlations between 10q and 20q. Other studies have looked into imprinted genes and their effect on obesity.

A study using an outbred animal model of obesity (M16 mice) suggested that such a model could be used to look at gene discovery and the pathways involved. The phenotype in mice mirrors the development of obesity in humans. A 1997 study considered the homology between human and animal models, with regards to estimating the number, location and effect of QTLs controlling obesity. The study looked forward to consider comparable “obesity maps” based on animals that were applicable in humans. The difficulties in reliably demonstrating genes involved in obesity are again shown in a paper describing common polygenetic obesity. Unconfirmed associations may be due to inadequate sample sizes or inadequate examination of variation within candidate genes.

Conclusion

Great strides have been made in recent times, elaborating our understanding of the genetic aspects of obesity. As mentioned, however, current knowledge outlined above only accounts for a small proportion of overall obesity levels observed at a population level. It is clear that significant investments still remain in order to elicit further detail of obesity genetics and to understand better how these various genetic components may be interlinked and ultimately predispose to the obesity phenotype. Translating our genetic discoveries into viable treatments to help alleviate the global health burden posed by the obesity epidemic will prove to be the ultimate challenge for the future.

Figures and Diagrams

You can also insert diagrams or photographs (to Upload files Cz:Upload)). These must be your own original work - and you will therefore be the copyright holder; of course they may be based on or adapted from diagrams produced by others - in which case this must be declared clearly, and the source of the orinal idea must be cited. When you insert a figure or diagram into your article you will be asked to fill out a form in which you declare that you are the copyright holder and that you are willing to allow your work to be freely used by others - choose the "Release to the Public Domain" option when you come to that page of the form.

When you upload your file, give it a short descriptive name, like "Adipocyte.png". Then, if you type {{Image|Adipocyte.png|right|300px|}} in your article, the image will appear on the right hand side.